Clinical trials

Researchers in China believe eating more fruit, dietary fibre, dairy products and caffeine may reduce the risk of tinnitus. To...

Australia’s Therapeutic Goods Administration (TGA) is evaluating Norgine Pharmaceutical’s PEDMARQSI for the prevention of hearing loss induced by cisplatin chemotherapy...

New Australian research suggests cochlear implants may improve cognitive function and slow dementia symptoms in older adults. Lead author, audiologist...

Ten of 12 children with profound genetic hearing loss who received Regeneron Pharmaceutical’s gene therapy showed ‘clinically meaningful, notable improvements...

America’s Food and Drug Administration (FDA) has approved Gomekli as the first drug to treat neurofibromatosis type 1 (NF1) in...

The Passe & Williams Foundation has announced 17 awardees, including many doing ear research, who will share in its 2025...

A feasibility study which evaluated the safety and performance of MED-EL’s novel totally implantable cochlear implant (TICI) suggests it can...

Researchers are investigating a novel molecule which they claim offers hope of an effective treatment for acute sudden hearing loss...

The latest NHMRC grants will fund brain stimulation treatment for tinnitus, and novel otitis media therapies including gel medication to...

Sensorion has provided gene therapy to two more toddlers with congenital deafness after the first child, an Australian infant, received...